Clinical trial
Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults…
NCT00109603 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00109603 |
|---|---|
| Title | Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy |
| Official title | A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | Tenofovir disoproxil fumarate |
| Enrollment | 17 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 2, 2005 |
| Last update posted | Oct 30, 2012 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: